A look at the growing ecosystem of open-weight models that run locally with no guardrails — private and uncensored by design — and the safety questions that follow when refusal is no longer part of the stack.

Early results on an experimental oral drug show promise against pancreatic cancer, one of the deadliest and most treatment-resistant cancers, where survival gains have been hard to come by for decades.

SoftBank is committing a major investment to expand AI data-center capacity in France, extending the global buildout of compute infrastructure into Europe.